JAHA:冠心病患者的心理疾病与随后的心血管事件

2019-05-04 xing.T 网络

由此可见,在患有冠状动脉疾病的患者中,较严重的心理疾病仅与女性未来的心血管事件有关。

各种较高水平的心理疾病指标与血管疾病(CVD)有关,尤其是女性。近日,血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员的目标是调查心理疾病复合指标与心血管事件之间的关联。

在一项前瞻性队列研究中,研究人员评估了662名患有稳定冠状动脉疾病的个体(28%为女性; 30%为黑人)。研究人员使用通过Z变换的心理痛苦症状量表(抑郁、创伤后应激、焦虑、愤怒、敌意和感知压力)得到心理疾病的综合评分作为不良事件(心血管死亡、心肌梗塞、卒中、心力衰竭或不稳定型心绞痛))复合终点的预测因子。

在平均2.8年的随访期间,120名(18%)受试者发生了CVD事件。在整体人群中,心理疾病指标与CVD事件之间没有关联,但存在基于性别的相互作用(P=0.004)。在女性中,较严重的心理疾病与CVD事件的发生率较高有关;心理疾病综合评分每增加SD与CVD事件的调整风险增加1.44倍相关(95%CI为1.09-1.92)。在男性中则没有发现这种关联。

由此可见,在患有冠状动脉疾病的患者中,较严重的心理疾病仅与女性未来的心血管事件有关。

原始出处:

Pratik Pimple.et al.Psychological Distress and Subsequent Cardiovascular Events in Individuals With Coronary Artery Disease.JAHA.2019.https://www.ahajournals.org/doi/full/10.1161/JAHA.118.011866

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1643607, encodeId=1eed164360ea8, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Mar 16 22:39:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268132, encodeId=8beb126813213, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447749, encodeId=065c144e749ca, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365741, encodeId=a197365e41f0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sun May 05 08:14:59 CST 2019, time=2019-05-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1643607, encodeId=1eed164360ea8, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Mar 16 22:39:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268132, encodeId=8beb126813213, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447749, encodeId=065c144e749ca, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365741, encodeId=a197365e41f0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sun May 05 08:14:59 CST 2019, time=2019-05-05, status=1, ipAttribution=)]
    2019-05-06 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1643607, encodeId=1eed164360ea8, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Mar 16 22:39:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268132, encodeId=8beb126813213, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447749, encodeId=065c144e749ca, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365741, encodeId=a197365e41f0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sun May 05 08:14:59 CST 2019, time=2019-05-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1643607, encodeId=1eed164360ea8, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Mar 16 22:39:00 CST 2020, time=2020-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268132, encodeId=8beb126813213, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447749, encodeId=065c144e749ca, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Mon May 06 13:39:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365741, encodeId=a197365e41f0, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sun May 05 08:14:59 CST 2019, time=2019-05-05, status=1, ipAttribution=)]
    2019-05-05 smartxiuxiu

    0

相关资讯

JAHA:性别对冠心病患者总疾病负担和预后的影响

总动脉粥样硬化疾病负担与冠心病患者的预后相关,然而,性别对总动脉粥样硬化疾病负担与预后并发症关系的影响尚不清楚。本研究纳入了1136名三条主要冠脉都接受了部分流量储备(FFR)检测的患者,通过SYNTAX 评分对患者的解剖和生理总疾病负担进行了评估,主要终点事件是主要不良心血管事件,2年的心源性死亡、心梗和缺血驱动的血运重建的复合事件。分析结果显示,男女性之间的冠脉直径和SYNTAX 评分无明显差

JAHA:DASH饮食可降低亚洲人群冠心病和卒中死亡风险

目前,在亚洲人群中还没有评估降血压式饮食(DASH)与中风和冠心病(CAD)死亡率的相关性,而矿物质摄入量作为潜在的中介物的作用还不清楚。本研究纳入了新加坡华人健康研究中的57078名参与者,在招募时,通过经验证的165项食物频率问卷收集了关于日常饮食的信息。分析结果显示,越贴近DASH饮食标准的饮食,CAD发病风险越低(HR: 0.76; 95% CI, 0.65-0.90; P<0.00

JACC:高密度脂蛋白相关评分可预测冠心病的发生和死亡

循环血中的脂蛋白浓度与冠心病的发病风险呈强相关。本研究的目的旨在高密度脂蛋白(HDL)体学评分(pCAD)对冠心病诊断和预后的影响。本研究对 CASABLANCA临床研究中的943名无心梗冠脉造影患者进行了HDL相关脂蛋白apoA1, apoC-1, apoC-2, apoC-3和apoC-4进行了检测,经过平均4年时间的随访,有587名患者出现了冠脉梗阻,pCAD评分与梗阻性冠心病的发生呈相关性

这10种疾病容易与“冠心病”混淆,临床上如何鉴别?

世界卫生组织将冠心病分为5大类:无症状心肌缺血(隐匿性冠心病)、心绞痛、心肌梗死、缺血性心力衰竭(缺血性心脏病)和猝死5种临床类型。我们今天就一起来分享一下,它们应该怎样与那些常见的疾病进行鉴别呢?

JACC:伴糖尿病冠心病患者PCI和CABG治疗预后无明显差异

EXCEL临床随机对照试验结果显示对于左主干冠脉(LMCAD)病变患者,冠脉搭桥(CABG)和经皮冠脉介入治疗(PCI)的三年主要终点事件发生率相似,然而这对于高风险患者如伴有糖尿病的患者是否有同样的结果尚不清楚。本研究纳入分析了1905例LMCAD病变患者,其中554名伴有糖尿病,随机1:1分至PCI支架植入组和CABG组,并根据是否有糖尿病进行分层,主要终点事件是3年全因死亡、卒中和心梗的复合

Eur Heart J:二甲双胍治疗无糖尿病冠心病患者左​​心室肥厚的疗效分析

由此可见,二甲双胍治疗显著降低LVMI、LVM、诊室收缩压、体重和氧化应激。虽然LVH是心血管(CV)结局的良好替代指标,但是需要大型CV结局试验来确切证明二甲双胍的心脏保护作用。